Greg Jennings’s AbbVie ABBV Stock Holding History

Greg Jennings’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7.31M	Buy	+27,954	New	+$7.17M	5.14%	8

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return

Greg Jennings's ABBV Position: Q3 2026 in Review

Greg Jennings opened a new position in AbbVie (ABBV) in Q3 2026: 27,954 shares worth $7.31M. The stake represents 5.14% of the portfolio and ranks #8 among its holdings.

1,900 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Greg Jennings held 27,954 shares of AbbVie worth $7.31M as of Q3 2026.
AbbVie was a new Greg Jennings position in Q3 2026.
AbbVie made up 5.14% of Greg Jennings's portfolio in Q3 2026, its #8 holding.
1,900 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Greg Jennings's 13F filing for Q3 2026, filed 19 Oct 2026.